Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIATREME RESOURCES LIMITED Capital/Financing Update 2013

Aug 15, 2013

64787_rns_2013-08-15_7e17f82b-fc04-4b73-85d0-b08cf03c2e14.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

DIATREME RESOURCES LIMITED

==> picture [71 x 74] intentionally omitted <==

ABN: 33 061 267 061

Postal Address: P.O Box 10288 Brisbane Adelaide Street QLD 4000 Registered Office: Level 2 87 Wickham Terrace Spring Hill QLD 4000 PH: +61 (0)7 3832 5666 FX: +61 (0)7 3832 5300 www.diatreme.com.au [email protected]

==> picture [39 x 40] intentionally omitted <==

ASX : DRX

Companies Announcement Office Australian Securities Exchange Level 4, 20 Bridge Street Sydney NSW 2000

16 August 2013

Information disclosed under ASX LR 3.10.5A and 7.1A.4(b)

Further to the ASX announcement and Appendix 3B lodged by Diatreme Resources Limited ( Diatreme ) on 16 August 2013 regarding completion of $1.2M of a previously disclosed $1.6M placement to sophisticated investors, Diatreme provides the following information under ASX Listing Rule 3.10.5A:

  • (a) A total of 60,000,000 shares were issued under the Placement. A total of 5,862,637 shares were issued pursuant to Listing Rule 7.1A (representing 0.99% of the post-placement capital) and 54,137,363 shares were issued pursuant to Listing Rule 7.1 (representing 9.18% of the post-placement capital).

The percentage of the post-placement capital held (in aggregate) is as follows:

  • pre-placement security holders who did not participate in the placement - 86.10%

  • pre-placement security holders who did participate in the placement – 7.12%

  • participants in the placement who were not previously security holders - 6.78%

  • (b) Diatreme considered the placement as the most efficient and expedient method for raising the funds required to achieve its stated objectives given the funding certainty. The Placement also allowed the Company to introduce a new sophisticated and professional investor to its register.

  • (c) The placement was not underwritten.

  • (d) A 6% commission was incurred by Diatreme in connection with the placement.

For further details, please contact:

Tuan Do Joint Company Secretary

ASX Release – 16 August 2013 (2)